Literature DB >> 25793938

Exquisitely specific bisubstrate inhibitors of c-Src kinase.

Kristoffer R Brandvold1, Shana M Santos1, Meghan E Breen1, Eric J Lachacz1, Michael E Steffey1, Matthew B Soellner1.   

Abstract

We have developed a modular approach to bisubstrate inhibition of protein kinases. We apply our methodology to c-Src and identify a highly selective bisubstrate inhibitor for this target. Our approach has yielded the most selective c-Src inhibitor to date, and the methodology to render the bisubstrate inhibitor cell-permeable provides a highly valuable tool for the study of c-Src signaling. In addition, we have applied our bisubstrate inhibitor to develop a novel screening methodology to identify non-ATP-competitive inhibitors of c-Src. Using this methodology, we have discovered the most potent non-ATP-competitive inhibitor reported to date. Our methodology is designed to be general and could be applicable to additional kinases inhibited by the promiscuous ATP-competitive fragment used in our studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25793938      PMCID: PMC4578647          DOI: 10.1021/cb501048b

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  24 in total

1.  Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.

Authors:  Jean Philippe Richard; Kamran Melikov; Eric Vives; Corinne Ramos; Birgit Verbeure; Mike J Gait; Leonid V Chernomordik; Bernard Lebleu
Journal:  J Biol Chem       Date:  2002-10-30       Impact factor: 5.157

Review 2.  Features of selective kinase inhibitors.

Authors:  Zachary A Knight; Kevan M Shokat
Journal:  Chem Biol       Date:  2005-06

Review 3.  Sounding the alarm: protein kinase cascades activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

Review 4.  Cellular functions regulated by Src family kinases.

Authors:  S M Thomas; J S Brugge
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

Review 5.  Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

Authors:  X Graña; E P Reddy
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

6.  In vivo protein transduction: delivery of a biologically active protein into the mouse.

Authors:  S R Schwarze; A Ho; A Vocero-Akbani; S F Dowdy
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

Review 7.  The hunting of the Src.

Authors:  G S Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

Review 8.  Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.

Authors:  C Widmann; S Gibson; M B Jarpe; G L Johnson
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

9.  Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.

Authors:  Xinmin Zheng; Ross J Resnick; David Shalloway
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

10.  The selectivity of protein kinase inhibitors: a further update.

Authors:  Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

View more
  6 in total

1.  Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.

Authors:  Dongxing Chen; Cheng Dong; Guangping Dong; Karthik Srinivasan; Jinrong Min; Nicholas Noinaj; Rong Huang
Journal:  J Med Chem       Date:  2020-07-16       Impact factor: 7.446

2.  Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.

Authors:  Sujata Chakraborty; Takayuki Inukai; Linglan Fang; Martin Golkowski; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

3.  Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity.

Authors:  Carrie M Gower; Jason R Thomas; Edmund Harrington; Jason Murphy; Matthew E K Chang; Ivan Cornella-Taracido; Rishi K Jain; Markus Schirle; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2015-11-06       Impact factor: 5.100

4.  Temporal Changes in Caspase-1 and Caspase-8 Activities Following Brain Hypoxia With and Without Src kinase Inhibition in a Piglet Animal Model.

Authors:  Dimitrios Angelis; Tania D Fontánez Nieves; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2015-09-05       Impact factor: 3.996

5.  Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles.

Authors:  Saadat Aleem; George Georghiou; Ralph E Kleiner; Kip Guja; Barbara P Craddock; Agatha Lyczek; Alix I Chan; Miguel Garcia-Diaz; W Todd Miller; David R Liu; Markus A Seeliger
Journal:  Cell Chem Biol       Date:  2016-09-01       Impact factor: 8.116

6.  Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase.

Authors:  Craig Fraser; John C Dawson; Reece Dowling; Douglas R Houston; Jason T Weiss; Alison F Munro; Morwenna Muir; Lea Harrington; Scott P Webster; Margaret C Frame; Valerie G Brunton; E Elizabeth Patton; Neil O Carragher; Asier Unciti-Broceta
Journal:  J Med Chem       Date:  2016-05-04       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.